ANI Pharmaceuticals Inc (NASDAQ:ANIP)

59.22
Delayed Data
As of Feb 16
 -0.50 / -0.84%
Today’s Change
42.23
Today|||52-Week Range
74.70
-8.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues38.2M36.6M44.8M48.2M
 
 
 
 
 
Cost of Goods Sold16.9M16.4M21.1M21.1M
 
 
 
 
 
Depreciation And Amortization5.8M6.7M7.1M7.1M
 
 
 
 
 
 
Operating ExpensesGross Income15.5M13.5M16.5M20.0M
 
 
 
 
 
General Expenses7.5M8.9M9.5M10.7M
 
 
 
 
 
Research And Development135.0K1.6M2.2M2.6M
 
 
 
 
 
Total Operating Expenses30.2M32.0M37.8M38.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.0M4.6M7.0M9.3M
 
 
 
 
 
Extraordinary Charge-6.7M0.000.000.00
 
 
Interest Expense On Debt2.9M3.0M3.2M3.2M
 
 
 
 
 
Other Expenses-43.0K-18.0K-19.0K95.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M1.7M4.0M6.4M
 
 
 
 
 
Income Taxes-524.0K-523.0K-1.3M-1.7M
 
 
 
 
 
Net Income-1.1M1.1M2.7M4.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.5M11.5M11.5M11.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.5M11.7M11.7M11.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09$0.10$0.23$0.40
 
 
 
 
 
EPS Diluted-$0.09$0.10$0.23$0.40